Skip to main content
Log in

Staphylococcus aureus septicaemia treated with cefotaxime

Therapie von Staphylococcus-aureus-Septikämien mit Cefotaxim

  • Originalia
  • Published:
Infection Aims and scope Submit manuscript

Summary

Staphylococcus aureus strains were exposedin vitro to continuously decreasing cefotaxime concentrations. The initial concentration was ∼4 × MIC and decreased at t1/2=60 min. A reduction in the colony count was seen even after the concentration had dropped below the MIC level. Sixteen patients with blood cultures positive forS. aureus were treated with cefotaxime. Four patients died of underlying diseases. The condition of one patient with staphylococcal endocarditis under treatment with vancomycin in combination with cefotaxime deteriorated when cefotaxime was discontinued, suggesting possible synergism between these two drugs against staphylococci.

Zusammenfassung

Staphylococcus-aureus-Stämme wurdenin vitro ständig abfallenden Cefotaxim-Konzentrationen ausgesetzt. Initiale Konzentrationen war 4 × MHK und die Verdünnungshalbwertszeit betrug 60 Minuten. Unter diesen Bedingungen war eine Keimzahlminderung auch nach Unterschreiten der MHK-Werte beobachtet worden. 16 Patienten mit Staphylokokken in der Blutkultur erhielten Cefotaxim. Vier Patienten starben an ihrer Grunderkrankung. Der Allgemeinzustand einer Patientin mit Endokarditis durchS. aureus, die Vancomycin in Kombination mit Cefotaxim erhielt, verschlechterte sich, als Cefotaxim abgesetzt wurde. Möglicherweise besteht zwischen Cefotaxim und Vancomycin ein Synergismus gegenS. aureus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature

  1. Shah, P. M., Helm, E. B., Stille, W.: Clinical experience with cefotaxime. 18th ICAAC, Atlanta 1978, Abstract 109.

  2. Blomer, R., Bruch, K.: Efficacy of cefotaxime in infections caused by gram-positive bacteria. III Mediterranean Congress of Chemotherapy, Dubrovnik 1982, Abstract 91.

  3. Shah, P. M. Antibacterial activity of cefotaxime and its clinical significance. Progr. Med. 2 (1982) 443–452.

    Google Scholar 

  4. Aschenbrenner, R., Baur, H., Bingold, K., Eyer, H., Franconi, G., Glanzmann, E., Gsell, O., Höring, F. O., Hottinger, A., Kleinschmidt, H., Löffler, W., Lüthy, F., Massini, R., Mohr, W., Nauck, E. G., Schlossberger, H. Infektionskrankheiten, Erster Teil. In:Bergmann, G. V., Frey, W., Schwiegk, H. (eds.): Handbuch der Inneren Medizin. Springer-Verlag, Berlin 1952, p. 723.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shah, P.M. Staphylococcus aureus septicaemia treated with cefotaxime. Infection 13 (Suppl 1), S34–S36 (1985). https://doi.org/10.1007/BF01644215

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01644215

Keywords

Navigation